Neurogenic atony of the urinary bladder

Drug	Drug Name	Drug Description
DB01019	Bethanechol	A muscarinic agonist used to treat postoperative and postpartum nonobstructive functional urinary retention and neurogenic atony of the bladder with retention.

Drug	Drug Name	Target	Type
DB01019	Bethanechol	Muscarinic acetylcholine receptor M2	target
DB01019	Bethanechol	Muscarinic acetylcholine receptor M1	target
DB01019	Bethanechol	Muscarinic acetylcholine receptor M3	target
DB01019	Bethanechol	Muscarinic acetylcholine receptor M4	target
DB01019	Bethanechol	Muscarinic acetylcholine receptor M5	target

Drug	Drug Name	Phase	Status	Count